吡唑并嘧啶作为靶向抗癌支架——综述。

IF 1.9 4区 医学 Q3 CHEMISTRY, MEDICINAL Medicinal Chemistry Pub Date : 2024-01-01 DOI:10.2174/0115734064251256231018104623
Kesavamoorthy Kandhasamy, Remya Ramachandran Surajambika, Pradeep Kumar Velayudham
{"title":"吡唑并嘧啶作为靶向抗癌支架——综述。","authors":"Kesavamoorthy Kandhasamy, Remya Ramachandran Surajambika, Pradeep Kumar Velayudham","doi":"10.2174/0115734064251256231018104623","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Globally, cancer is the leading cause of death, which causes 10 million deaths yearly. Clinically, several drugs are used in treatment but due to drug resistance and multidrug resistance, there occurs a failure in the cancer treatment.</p><p><strong>Objectives: </strong>The present review article is a comprehensive review of pyrazole and pyrimidine hybrids as potential anticancer agents.</p><p><strong>Methods: </strong>The review comprises more than 60 research works done in this field. The efficiency of the reported pyrazolopyrimidine fused heterocyclic with their biological data and the influence of the structural aspects of the molecule have been discussed.</p><p><strong>Results: </strong>This review highlighted pyrazolo-pyrimidines as targeted anticancer agents with effect on multiple targets.</p><p><strong>Conclusion: </strong>The review will be helpful for the researchers involved in targeted drugs for cancer therapy for designing new scaffolds with pyrazolo-pyrimidine moieties.</p>","PeriodicalId":18382,"journal":{"name":"Medicinal Chemistry","volume":null,"pages":null},"PeriodicalIF":1.9000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Pyrazolo - Pyrimidines as Targeted Anticancer Scaffolds - A Comprehensive Review.\",\"authors\":\"Kesavamoorthy Kandhasamy, Remya Ramachandran Surajambika, Pradeep Kumar Velayudham\",\"doi\":\"10.2174/0115734064251256231018104623\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Globally, cancer is the leading cause of death, which causes 10 million deaths yearly. Clinically, several drugs are used in treatment but due to drug resistance and multidrug resistance, there occurs a failure in the cancer treatment.</p><p><strong>Objectives: </strong>The present review article is a comprehensive review of pyrazole and pyrimidine hybrids as potential anticancer agents.</p><p><strong>Methods: </strong>The review comprises more than 60 research works done in this field. The efficiency of the reported pyrazolopyrimidine fused heterocyclic with their biological data and the influence of the structural aspects of the molecule have been discussed.</p><p><strong>Results: </strong>This review highlighted pyrazolo-pyrimidines as targeted anticancer agents with effect on multiple targets.</p><p><strong>Conclusion: </strong>The review will be helpful for the researchers involved in targeted drugs for cancer therapy for designing new scaffolds with pyrazolo-pyrimidine moieties.</p>\",\"PeriodicalId\":18382,\"journal\":{\"name\":\"Medicinal Chemistry\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.9000,\"publicationDate\":\"2024-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medicinal Chemistry\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.2174/0115734064251256231018104623\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"CHEMISTRY, MEDICINAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicinal Chemistry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2174/0115734064251256231018104623","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0

摘要

背景:在全球范围内,癌症是主要的死亡原因,每年导致1000万人死亡。临床上,有几种药物用于治疗,但由于耐药性和多药耐药性,癌症治疗会失败。目的:综述吡唑和嘧啶杂化物作为潜在抗癌药物的研究进展。方法:综述了该领域60多项研究成果。讨论了已报道的吡唑并嘧啶稠合杂环的效率及其生物学数据以及分子结构方面的影响。结果:本文着重介绍吡唑并嘧啶类药物作为靶向抗癌药物,具有多种靶点作用。结论:该综述将有助于癌症靶向药物研究人员设计吡唑并嘧啶部分的新型支架。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Pyrazolo - Pyrimidines as Targeted Anticancer Scaffolds - A Comprehensive Review.

Background: Globally, cancer is the leading cause of death, which causes 10 million deaths yearly. Clinically, several drugs are used in treatment but due to drug resistance and multidrug resistance, there occurs a failure in the cancer treatment.

Objectives: The present review article is a comprehensive review of pyrazole and pyrimidine hybrids as potential anticancer agents.

Methods: The review comprises more than 60 research works done in this field. The efficiency of the reported pyrazolopyrimidine fused heterocyclic with their biological data and the influence of the structural aspects of the molecule have been discussed.

Results: This review highlighted pyrazolo-pyrimidines as targeted anticancer agents with effect on multiple targets.

Conclusion: The review will be helpful for the researchers involved in targeted drugs for cancer therapy for designing new scaffolds with pyrazolo-pyrimidine moieties.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Medicinal Chemistry
Medicinal Chemistry 医学-医药化学
CiteScore
4.30
自引率
4.30%
发文量
109
审稿时长
12 months
期刊介绍: Aims & Scope Medicinal Chemistry a peer-reviewed journal, aims to cover all the latest outstanding developments in medicinal chemistry and rational drug design. The journal publishes original research, mini-review articles and guest edited thematic issues covering recent research and developments in the field. Articles are published rapidly by taking full advantage of Internet technology for both the submission and peer review of manuscripts. Medicinal Chemistry is an essential journal for all involved in drug design and discovery.
期刊最新文献
In Silico Studies of Phytoconstituents to Identify Potential Inhibitors for ERα Protein of Breast Cancer A Preclinical Study on 4-Methyl-N-((4-(trifluoromethoxy)phenyl) carbamoyl)-benzenesulfonamide as a Potent Chemotherapeutic Agent against Liver and Pancreatic Carcinogenesis in Rats: Immunohistochemical and Histopathological Studies Exploring the Diverse Therapeutic Applications of 1, 3-Thiazine: A Comprehensive Review Unveiling the Anti-cancer Potential of Oxadiazole Derivatives: A Comprehensive Exploration of Structure-Activity Relationships and Chemico-Biological Insights Recent Advances in Anticancer Research of Osmium and Rhodium Complexes
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1